Pottecher Julien, Adamopoulos Chris, Lejay Anne, Bouitbir Jamal, Charles Anne-Laure, Meyer Alain, Singer Mervyn, Wolff Valerie, Diemunsch Pierre, Laverny Gilles, Metzger Daniel, Geny Bernard
Fédération de Médecine Translationnelle de Strasbourg, Faculté de Médecine, Institut de Physiologie, Equipe d'Accueil EA3072 "Mitochondrie, Stress Oxydant et Protection Musculaire", Université de Strasbourg, Strasbourg, France.
Pôle Anesthésie Réanimations Chirurgicales SAMU/SMUR (POLARS), Hôpital de Hautepierre, Service d'Anesthésie-Réanimation Chirurgicale, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Front Physiol. 2018 May 22;9:579. doi: 10.3389/fphys.2018.00579. eCollection 2018.
Diabetic patients respond poorly to revascularization for peripheral arterial disease (PAD) but the underlying mechanisms are not well understood. We aimed to determine whether diabetes worsens ischemia-reperfusion (IR)-induced muscle dysfunction and the involvement of endogenous protective kinases in this process. Streptozotocin-induced diabetic and non-diabetic rats were randomized to control or to IR injury (3 h of aortic cross-clamping and 2 h of reperfusion). Mitochondrial respiration, reactive oxygen species (ROS) production, protein levels of superoxide dismutase (SOD2) and endogenous protective kinases (RISK and SAFE pathways) were investigated in rat gastrocnemius, together with upstream (GSK-3β) and downstream (cleaved caspase-3) effectors of apoptosis. Although already impaired when compared to non-diabetic controls at baseline, the decline in mitochondrial respiration after IR was more severe in diabetic rats. In diabetic animals, IR-triggered oxidative stress (increased ROS production and reduced SOD2 levels) and effectors of apoptosis (reduced GSK-3β inactivation and higher cleaved caspase-3 levels) were increased to a higher level than in the non-diabetics. IR had no effect on the RISK pathway in non-diabetics and diabetic rats, but increased STAT 3 only in the latter. Type 1 diabetes worsens IR-induced skeletal muscle injury, endogenous protective pathways not being efficiently stimulated.
糖尿病患者对周围动脉疾病(PAD)的血管重建反应不佳,但其潜在机制尚未完全明确。我们旨在确定糖尿病是否会加重缺血再灌注(IR)诱导的肌肉功能障碍以及内源性保护激酶在此过程中的作用。将链脲佐菌素诱导的糖尿病大鼠和非糖尿病大鼠随机分为对照组或IR损伤组(主动脉交叉夹闭3小时和再灌注2小时)。研究了大鼠腓肠肌中的线粒体呼吸、活性氧(ROS)生成、超氧化物歧化酶(SOD2)的蛋白水平以及内源性保护激酶(RISK和SAFE通路),同时还研究了凋亡的上游(GSK-3β)和下游(裂解的半胱天冬酶-3)效应器。尽管与非糖尿病对照组相比,糖尿病大鼠在基线时线粒体呼吸功能就已受损,但IR后糖尿病大鼠线粒体呼吸功能的下降更为严重。在糖尿病动物中,IR引发的氧化应激(ROS生成增加和SOD2水平降低)以及凋亡效应器(GSK-3β失活减少和裂解的半胱天冬酶-3水平升高)比非糖尿病动物增加到更高水平。IR对非糖尿病大鼠和糖尿病大鼠的RISK通路均无影响,但仅在糖尿病大鼠中增加了STAT 3。1型糖尿病会加重IR诱导的骨骼肌损伤,内源性保护通路未得到有效激活。